Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pancreatic carcinoma
|
322 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.800 | 1.000 | 2 | 2012 | 2017 | ||||
Malignant neoplasm of stomach
|
615 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.100 | 0.700 | 10 | 2014 | 2019 | ||||
Stomach Carcinoma
|
652 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.100 | 0.700 | 10 | 2014 | 2019 | ||||
Asthma
|
1536 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.080 | 1.000 | 8 | 2006 | 2018 | ||||
Rheumatoid Arthritis
|
2387 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.060 | 1.000 | 6 | 2010 | 2020 | ||||
Tuberculosis
|
328 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.060 | 0.833 | 6 | 2013 | 2019 | ||||
Psoriasis
|
705 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.050 | 1.000 | 5 | 2015 | 2019 | ||||
Colorectal Carcinoma
|
1962 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.040 | 1.000 | 4 | 2015 | 2019 | ||||
Osteoarthritis, Knee
|
150 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.040 | 1.000 | 4 | 2019 | 2019 | ||||
cervical cancer
|
268 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.030 | 1.000 | 3 | 2015 | 2017 | ||||
Cervix carcinoma
|
283 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.030 | 1.000 | 3 | 2015 | 2017 | ||||
Malignant Neoplasms
|
1641 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.030 | 0.667 | 3 | 2014 | 2016 | ||||
Malignant tumor of cervix
|
245 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.030 | 1.000 | 3 | 2015 | 2017 | ||||
Periodontitis
|
116 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.030 | 1.000 | 3 | 2013 | 2017 | ||||
Primary malignant neoplasm
|
1374 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.030 | 0.667 | 3 | 2014 | 2016 | ||||
Ulcerative Colitis
|
827 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.030 | 0.667 | 3 | 2008 | 2013 | ||||
Autoimmune thrombocytopenia
|
7 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.020 | 1.000 | 2 | 2017 | 2019 | ||||
Chronic Obstructive Airway Disease
|
852 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.020 | 1.000 | 2 | 2006 | 2019 | ||||
Crohn Disease
|
1147 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.020 | 1.000 | 2 | 2008 | 2013 | ||||
Graves Disease
|
352 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||
Hashimoto Disease
|
131 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||
Immune thrombocytopenic purpura
|
35 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.020 | 1.000 | 2 | 2017 | 2019 | ||||
Inflammatory Bowel Diseases
|
605 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.020 | 0.500 | 2 | 2008 | 2017 | ||||
Leprosy
|
120 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.020 | 1.000 | 2 | 2014 | 2019 | ||||
Lupus Erythematosus, Systemic
|
1172 | 0.531 | 0.720 | 6 | 52236941 | missense variant | T/C | snv | 6.7E-02 | 6.6E-02 | 0.020 | 1.000 | 2 | 2016 | 2016 |